Moody’s credit quality of A3 or better

Healthcare Sector

Click company for information about its Direct Investment Plan (DRP or DRIP).

Abbott Laboratories (ABT)– A2

AstraZeneca PLC (AZN)– A2

Bristol-Myers Squibb Co. (BMY)– A2

Eli Lilly & Company (LLY)– A2

Gilead Sciences Inc. (GILD)– A3

Johnson & Johnson (JNJ)– Aaa

Medtronic plc (MDT)– A3

Merck & Company Inc. (MRK)– A1

Pfizer Inc. (PFE)– A2

United Health Group Incorporated (UNH)– A2